Company · CIK 0001764013 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Immunovant, Inc. · IMVT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 25, 4:05 pm EDT | Christopher Van TuylChief Legal Officer | 2,846 | $36.36 | $103,481 | 176,545 | −1.59% | |
| Aug 28, 2026 SForm 4 → | Aug 28, 4:27 pm EDT | Atul PandeDirector | 1,500 | $43.27 | $64,905 | 116,731 | −1.27% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 28, 4:27 pm EDT | Atul PandeDirector | 1,500 | $8.43 | $12,645 | 118,231 | — | 10b5-1 |
| Aug 20, 2026 SForm 4 → | Aug 21, 4:03 pm EDT | Melanie GloriaChief Operating Officer | 3,056 | $44.16 | $134,953 | 219,301 | −1.37% | |
| Jul 24, 2026 SForm 4 → | Jul 24, 5:59 pm EDT | Atul PandeDirector | 1,500 | $39.80 | $59,700 | 116,731 | −1.27% | 10b5-1 |
| Jul 24, 2026 MForm 4 → | Jul 24, 5:59 pm EDT | Atul PandeDirector | 1,500 | $8.43 | $12,645 | 118,231 | — | 10b5-1 |
| Jul 23, 2026 SForm 4 → | Jul 24, 5:57 pm EDT | Tiago GiraoChief Financial Officer | 6,798 | $38.69 | $263,015 | 240,798 | −2.75% | |
| Jul 23, 2026 SForm 4 → | Jul 24, 5:57 pm EDT | Jay S StoutChief Technology Officer | 2,857 | $38.69 | $110,537 | 205,341 | −1.37% | |
| Jul 8, 2026 SForm 4 → | Jul 10, 4:15 pm EDT | Melanie GloriaChief Operating Officer | 2,036 | $39.55 | $80,532 | 222,357 | −0.91% | |
| Jul 8, 2026 SForm 4 → | Jul 10, 4:13 pm EDT | Christopher Van TuylChief Legal Officer | 1,206 | $39.55 | $47,702 | 179,391 | −0.67% | |
| Jul 8, 2026 SForm 4 → | Jul 10, 4:12 pm EDT | Jay S StoutChief Technology Officer | 3,487 | $39.55 | $137,925 | 208,198 | −1.65% | |
| Jul 2, 2026 SForm 4 → | Jul 6, 5:01 pm EDT | Eric VenkerChief Executive Officer, Director | 3,092 | $38.48 | $118,980 | 254,280 | −1.20% | |
| Jul 1, 2026 DMForm 4 → | Jul 6, 5:01 pm EDT | Eric VenkerChief Executive Officer, Director | 178,817 | $25.93 | $4,637,069 | 257,372 | — | |
| Jun 26, 2026 SForm 4 → | Jun 26, 7:46 pm EDT | Melanie GloriaChief Operating Officer | 17,714 | $38.31 | $678,604 | 224,393 | −7.32% | |
| Jun 26, 2026 SForm 4 → | Jun 26, 7:45 pm EDT | Jay S StoutChief Technology Officer | 40,000 | $38.31 | $1,532,309 | 211,685 | −15.9% | |
| Jun 26, 2026 SForm 4 → | Jun 26, 7:45 pm EDT | Christopher Van TuylChief Legal Officer | 17,824 | $38.31 | $682,887 | 180,597 | −8.98% | |
| Jun 26, 2026 MForm 4 → | Jun 26, 7:45 pm EDT | Christopher Van TuylChief Legal Officer | 17,824 | $15.20 | $270,925 | 198,421 | — | |
| Jun 26, 2026 SForm 4 → | Jun 26, 7:44 pm EDT | Tiago GiraoChief Financial Officer | 10,000 | $38.46 | $384,600 | 247,596 | −3.88% | |
| Jun 26, 2026 MForm 4 → | Jun 26, 7:44 pm EDT | Tiago GiraoChief Financial Officer | 10,000 | $15.90 | $159,000 | 257,596 | — | |
| Jun 26, 2026 SForm 4 → | Jun 26, 7:43 pm EDT | Atul PandeDirector | 1,500 | $38.01 | $57,015 | 116,731 | −1.27% | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 26, 7:43 pm EDT | Atul PandeDirector | 1,500 | $8.43 | $12,645 | 118,231 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 MForm 4 → | Aug 28, 4:27 pm EDT | Atul PandeDirector | 1,500 | — | — | 65,181 | — | 10b5-1 |
| Jul 24, 2026 MForm 4 → | Jul 24, 5:59 pm EDT | Atul PandeDirector | 1,500 | — | — | 66,681 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 5:01 pm EDT | Eric VenkerChief Executive Officer, Director | 92,188 | — | — | 1,014,062 | — | |
| Jun 26, 2026 MForm 4 → | Jun 26, 7:45 pm EDT | Christopher Van TuylChief Legal Officer | 17,824 | — | — | 53,707 | — | |
| Jun 26, 2026 MForm 4 → | Jun 26, 7:44 pm EDT | Tiago GiraoChief Financial Officer | 10,000 | — | — | 283,505 | — | |
| Jun 26, 2026 MForm 4 → | Jun 26, 7:43 pm EDT | Atul PandeDirector | 1,500 | — | — | 68,181 | — | 10b5-1 |